Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03245450 |
|---|---|
| Brief Title: | Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors |
| First Submitted : | August 8, 2017 |
| First Submitted that Met QC Criteria : | August 8, 2017 |
| First Posted : | August 10, 2017 |
| Results First Submitted : | May 16, 2022 |
| Results First Posted with QC Comments : | June 13, 2022 |
| Results First Submitted that Met QC Criteria : | June 20, 2022 |
| Results First Posted : | June 28, 2022 |
| Last Update Submitted that Met QC Criteria : | June 20, 2022 |
| Last Update Posted : | June 28, 2022 |